Atanas G. Atanasov is Principle Investigator of Ludwig Boltzmann Institute for Digital Health and Patient Safety (LBI-DHPS) at Medical University of Vienna (Austria), Professor of IGAB PAS (Poland), and Editor-in-Chief of Current Research in Biotechnology (#CRBIOTECH) and Exploration of Digital Health Technologies (#ExplorDHT).
Dr Atanasov holds MSc in Biotechnology (from the University of Sofia, Bulgaria), PhD in Biochemistry (from the University of Bern, Switzerland), and Habilitation (Dr. habil. / PD) in Pharmaceutical Biology (from the University of Vienna, Austria). He has published >350 papers in the areas of Molecular Medicine, Public Health, Digital Health Technologies, Biotechnology, Natural Products, Nutrition, Science Communication, Innovation, and Molecular Pharmacology. Moreover, Dr Atanas G. Atanasov is ranked as a Cross-Field Highly Cited Researcher (by Clarivate, 2021-2023 data), is included in the World’s Top 2% Scientists list (by Stanford University/Scopus/Elsevier 2024 data), and is a distinguished promoter of digital science communication (including use of social media, e.g., a >100 000-followers X (formerly Twitter)) and open innovation (e.g., through the executive leadership of open innovation platforms focused on Digital Health and Patient Safety (#DHPSP) and on Natural Product Research (#INPST)).